TOLL-LIKE RECEPTOR AGONIST FORMULATIONS AND THEIR USE

The present invention is directed generally to stable formulations of a TLR agonist preferably a TLR7 or a TLR8 agonist, for use in the treatment of cancer, preferably solid tumors and lymphomas. Specifically, the present invention is directed to stable formulations of up to 50 mg/ml of a TLR agonis...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	HOWBERT, J., JEFFRY, HERSHBERG, ROB, DUVVURI, MURALIKRISHNA, DIETSCH, GREG
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!